Multimonth,O
Dispensing,O
of,O
Antiretroviral,O
Therapy,O
Protects,O
the,O
Most,O
Vulnerable,O
From,O
2,NUMBER
Pandemics,O
at,O
Once,DATE
Ariana,O
Moriah,O
Traub,O
.,O
a,O
Temi,O
‐,O
tayo,PERSON
Ifafore,PERSON
‐,PERSON
Calfee,PERSON
.,O
b,O
Benjamin,PERSON
Ryan,PERSON
Phelpsb,PERSON
Key,O
Messages,O
Multi,O
‐,O
month,DURATION
dispensing,O
.,O
which,O
provides,O
patients,O
with,O
several,DURATION
months,DURATION
of,O
antiretroviral,O
therapy,O
.,O
benefits,O
HIV,CAUSE_OF_DEATH
patients,O
by,O
decreasing,O
the,O
number,O
of,O
required,O
clinic,O
visits,O
.,O
improving,O
retention,O
.,O
and,O
im,O
‐,O
proving,O
viral,O
suppression,O
.,O
With,O
the,O
increased,O
spread,O
of,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
2,NUMBER
.,O
we,O
encourage,O
govern,O
‐,O
ments,O
.,O
ministries,O
of,O
health,O
.,O
and,O
health,O
care,O
facilities,O
to,O
imple,O
‐,O
ment,O
multimonth,O
reduce,O
clinic,O
visits,O
and,O
safeguard,O
both,O
health,O
care,O
workers,O
and,O
patients,O
from,O
coronavirus,O
disease,CAUSE_OF_DEATH
ince,O
the,O
emer,O
‐,O
gence,O
of,O
the,O
severe,O
acute,O
respiratory,O
syndrome,O
coronavirus,O
2,NUMBER
(,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
),O
in,O
December,DATE
2019,DATE
.,O
the,O
virus,O
has,O
been,O
identified,O
in,O
more,O
than,O
183,NUMBER
countries,O
.1,NUMBER
Its,O
rapid,O
spread,O
is,O
of,O
major,O
concern,O
for,O
those,O
living,O
in,O
low,O
‐,O
and,O
middle,O
‐,O
income,O
countries,O
and,O
specifi,O
‐,O
cally,O
people,O
living,O
with,O
HIV,CAUSE_OF_DEATH
(,O
PLHIV,O
),O
.,O
With,O
the,O
dearth,O
of,O
studies,O
on,O
HIV,CAUSE_OF_DEATH
‐,O
coronavirus,O
disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
coinfections,O
.,O
coun,O
‐,O
tries,O
have,O
no,O
clear,O
evidence,O
on,O
specific,O
risks,O
for,O
PLHIV,O
.2.3,NUMBER
How,O
‐,O
ever,O
.,O
as,O
with,O
other,O
infectious,O
diseases,CAUSE_OF_DEATH
.,O
it,O
is,O
expected,O
that,O
PL,O
‐,O
HIV,CAUSE_OF_DEATH
who,O
are,O
not,O
virally,O
suppressed,O
and,O
/,O
or,O
on,O
antiretroviral,O
ther,O
‐,O
apy,O
(,O
ART,O
),O
might,O
be,O
at,O
an,O
increased,O
risk,O
of,O
COVID19,O
infection,CAUSE_OF_DEATH
.,O
se,O
‐,O
vere,O
disease,CAUSE_OF_DEATH
.,O
and,O
poor,O
health,O
outcomes,O
.2.3,NUMBER
Thus,O
.,O
every,O
precaution,O
must,O
be,O
taken,O
to,O
avoid,O
HIV,CAUSE_OF_DEATH
‐,O
COVID,O
‐,O
19,NUMBER
coinfection,O
and,O
keep,O
the,O
num,O
‐,O
ber,O
of,O
COVID,O
‐,O
19,NUMBER
cases,O
at,O
a,O
minimum,O
in,O
countries,O
with,O
high,O
propor,O
‐,O
tions,O
of,O
PLHIV,O
.,O
To,O
minimize,O
the,O
spread,O
of,O
COVID,O
‐,O
19,NUMBER
.,O
PLHIV,O
are,O
encouraged,O
to,O
follow,O
public,O
health,O
guidelines,O
to,O
limit,O
in,O
‐,O
person,O
interactions,O
and,O
general,TITLE
mitigation,O
recommendations,O
.,O
including,O
social,O
distancing,O
and,O
good,O
hand,O
hygiene,O
.,O
Refilling,O
lifesaving,O
an,O
‐,O
tiretroviral,O
drugs,CRIMINAL_CHARGE
requires,O
interpersonal,O
interaction,O
and,O
brings,O
the,O
potential,O
of,O
Sustaining,O
Technical,O
and,O
Analytic,O
Resources,O
.,O
United,ORGANIZATION
States,ORGANIZATION
Agency,ORGANIZATION
for,ORGANIZATION
International,ORGANIZATION
Development,ORGANIZATION
(,O
USAID,ORGANIZATION
),O
.,O
Wash,STATE_OR_PROVINCE
‐,O
ington,O
.,O
DC,STATE_OR_PROVINCE
.,O
USA,COUNTRY
.,O
Office,O
of,O
HIV,CAUSE_OF_DEATH
/,CAUSE_OF_DEATH
AIDS,CAUSE_OF_DEATH
.,O
USAID,LOCATION
.,O
Washington,CITY
.,CITY
DC,CITY
.,O
USA,COUNTRY
.,O
Global,O
Health,O
:,O
Science,O
and,O
Practice,O
2020,DATE
|,O
Volume,O
8,NUMBER
|,O
Number,O
2,NUMBER
increasing,O
the,O
spread,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
and,O
other,O
transmissible,O
dis,O
‐,O
eases,O
.,O
Thus,O
.,O
policy,O
makersincluding,O
the,O
U.S.,COUNTRY
Presidents,O
Emergency,O
Plan,O
for,O
AIDS,CAUSE_OF_DEATH
Reliefare,MISC
encouraging,O
countries,O
to,O
provide,O
PLHIV,O
with,O
a,O
multimonth,O
supply,O
of,O
ART,O
as,O
a,O
key,O
strategy,O
to,O
safeguard,O
PLHIV,O
and,O
health,O
care,O
workers,O
involved,O
in,O
providing,O
HIV,CAUSE_OF_DEATH
ser,O
‐,O
vices,O
.4,NUMBER
MULTIMONTH,O
ART,O
DISPENSING,O
MITIGATES,O
RISK,O
OF,O
HIV,CAUSE_OF_DEATH
AND,O
COVID,O
‐,O
19,NUMBER
Multimonth,O
dispensing,O
(,O
MMD,O
),O
is,O
an,O
aspect,O
of,O
differenti,O
‐,O
ated,O
service,O
delivery,O
that,O
provides,O
patients,O
with,O
either,O
3,NUMBER
or,O
6,NUMBER
months,DURATION
of,O
medication,O
and,O
eliminates,O
the,O
need,O
for,O
monthly,SET
clinic,O
and,O
/,O
or,O
community,O
facility,O
visits,O
.,O
From,O
the,O
patients,O
perspective,O
.,O
MMD,ORGANIZATION
has,O
already,O
been,O
shown,O
to,O
reduce,O
the,O
cost,O
of,O
travel,O
.,O
reduce,O
patient,O
burden,O
.,O
and,O
MMD,ORGANIZATION
improves,O
adherence,O
and,O
viral,O
suppres,O
‐,O
sion,O
.5.7,NUMBER
In,O
the,O
context,O
of,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
this,O
viral,O
sup,O
‐,O
pression,O
strengthens,O
the,O
immune,O
system,O
and,O
likely,O
mitigates,O
the,O
risk,O
of,O
severe,O
COVID,O
‐,O
19.8,NUMBER
MMD,O
.,O
essential,O
to,O
caring,O
for,O
PLHIV,O
.,O
is,O
arguably,O
even,O
more,O
critical,O
during,O
the,O
COVID,O
‐,O
19,NUMBER
pandemic,O
.,O
Cur,O
‐,O
rently,O
.,O
only,O
21,NUMBER
countries,O
have,O
formal,O
6,NUMBER
‐,O
month,DURATION
dispensing,O
poli,O
‐,O
cies,O
.,O
Two,NUMBER
countries,O
allow,O
clinicians,O
to,O
provide,O
6,NUMBER
‐,O
month,DURATION
supply,O
when,O
they,O
deem,O
appropriate,O
.,O
and,O
8,NUMBER
countries,O
have,O
a,O
3,NUMBER
‐,O
month,DURATION
dis,O
‐,O
pensing,O
policy,O
in,O
place,O
.,O
South,COUNTRY
Africa,COUNTRY
.,O
the,O
country,O
with,O
the,O
largest,O
number,O
of,O
PLHIV,O
.,O
only,O
has,O
a,O
2,NUMBER
‐,O
month,DURATION
dispensing,O
policy,O
in,O
place,O
.,O
To,O
mitigate,O
the,O
damage,O
caused,O
by,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
while,O
pro,O
‐,O
tecting,O
the,O
health,O
of,O
PLHIV,O
.,O
we,O
encourage,O
countries,O
to,O
rapidly,O
implement,O
3,NUMBER
‐,O
month,DURATION
if,O
not,O
6,NUMBER
‐,O
month,DURATION
dispensing,O
.,O
As,O
a,O
key,O
strategy,O
to,O
safeguard,O
patients,O
and,O
health,O
care,O
workers,O
providing,O
HIV,CAUSE_OF_DEATH
ser,O
‐,O
vices,O
.,O
MMD,ORGANIZATION
also,O
reduces,O
clinic,O
visits,O
.,O
improves,O
viral,O
suppres,O
‐,O
sion,O
.,O
encourages,O
social,O
distancing,O
.,O
and,O
potentially,O
saves,O
pa,O
‐,O
tients,O
from,O
the,O
dual,O
threat,O
of,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
and,O
HIV,CAUSE_OF_DEATH
.,O
As,O
SARS,O
‐,O
CoV,O
‐,O
2,NUMBER
spreads,O
.,O
patient,O
caseloads,O
are,O
likely,O
to,O
increase,O
across,O
low,O
‐,O
and,O
middle,O
‐,O
income,O
countries,O
will,O
protect,O
the,O
time,O
and,O
health,O
of,O
ex,O
‐,O
isting,O
health,O
care,O
professionals,O
and,O
ready,O
our,O
health,O
systems,O
for,O
imminent,O
threats,O
as,O
well,O
as,O
any,O
that,O
may,O
follow,O
.,O
Multimonth,O
An,O
‐,O
tiretroviral,O
Therapy,O
Dispensing,O
Protects,O
Against,O
2,NUMBER
Pandemics,O
1,NUMBER
.,O
Dong,PERSON
E,PERSON
.,O
Du,PERSON
H,PERSON
.,O
Gardner,PERSON
L,O
.,O
An,O
interactive,O
web,O
‐,O
based,O
dashboard,O
to,O
track,O
COVID,O
‐,O
19,NUMBER
in,O
real,O
time,O
.,O
Lancet,O
Infect,O
Dis,O
.,O
2020,DATE
.,O
CrossRef,O
.,O
2,NUMBER
.,O
Centers,ORGANIZATION
for,ORGANIZATION
Disease,ORGANIZATION
Control,ORGANIZATION
and,ORGANIZATION
Prevention,ORGANIZATION
.,O
What,O
to,O
Know,O
About,O
3,NUMBER
.,O
U.S.,ORGANIZATION
Department,ORGANIZATION
of,ORGANIZATION
Health,ORGANIZATION
and,ORGANIZATION
Human,ORGANIZATION
Services,ORGANIZATION
.,O
Interim,O
interim,O
‐,O
guidance,O
‐,O
/,O
554,NUMBER
/,O
interim,O
‐,O
guidance,O
‐,O
for,O
‐,O
covid,O
‐,O
19,NUMBER
‐,O
andpersons,O
‐,O
with,O
‐,O
hiv,CAUSE_OF_DEATH
.,O
Updated,O
April,DATE
21,DATE
.,DATE
2020,DATE
.,O
Accessed,O
March,DATE
31,DATE
.,O
4,NUMBER
.,O
U.S.,COUNTRY
Presidents,O
Emergency,O
Plan,O
for,O
AIDS,CAUSE_OF_DEATH
Relief,MISC
.,O
PEPFARs,O
HIV,CAUSE_OF_DEATH
Response,O
in,O
the,O
Con,O
‐,O
text,O
of,O
Coronavirus,O
Disease,CAUSE_OF_DEATH
2019,DATE
(,O
COVID,O
‐,O
19,NUMBER
),O
.,O
2020,DATE
.,O
Accessed,O
April,DATE
9,DATE
.,DATE
2020,DATE
.,O
5,NUMBER
.,O
Faturiyele,ORGANIZATION
IO,ORGANIZATION
.,O
Appolinare,O
T,O
.,O
Ngorima,PERSON
‐,PERSON
Mabhena,PERSON
N,O
.,O
et,O
al,O
.,O
trial,O
protocol,O
.,O
BMC,ORGANIZATION
Public,ORGANIZATION
Health,ORGANIZATION
.,O
2018,DATE
;,O
18,NUMBER
(,O
1,NUMBER
),O
:,O
1069,DATE
.,O
CrossRef,O
.,O
6,NUMBER
.,O
Babigumira,PERSON
JB,PERSON
.,O
Castelnuevo,O
B,O
.,O
Stergachis,PERSON
A,O
.,O
et,O
al,O
.,O
Cost,O
effectiveness,O
of,O
a,O
pharmacy,O
‐,O
only,O
refill,O
program,O
in,O
a,O
large,O
urban,O
HIV,CAUSE_OF_DEATH
/,CAUSE_OF_DEATH
AIDS,CAUSE_OF_DEATH
clinic,O
in,O
Uganda,COUNTRY
.,O
PloS,O
One,NUMBER
.,O
2011,DATE
;,O
6,NUMBER
(,O
3,NUMBER
),O
:,O
e18193,O
.,O
CrossRef,O
.,O
Medline,ORGANIZATION
7,NUMBER
.,O
Prust,ORGANIZATION
ML,ORGANIZATION
.,O
Banda,PERSON
CK,PERSON
.,O
Nyirenda,PERSON
R,PERSON
.,O
et,O
al,O
.,O
Mul,O
‐,O
ti,O
‐,O
month,DURATION
prescriptions,O
.,O
fasttrack,O
refills,O
.,O
and,O
community,O
ART,O
groups,O
:,O
results,O
from,O
a,O
process,O
evaluation,O
in,O
Malawi,COUNTRY
on,O
using,O
dif,O
‐,O
ferentiated,O
models,O
of,O
care,O
to,O
achieve,O
national,O
HIV,CAUSE_OF_DEATH
treatment,O
goals,O
.,O
J,O
Int,O
AIDS,CAUSE_OF_DEATH
Soc,O
.,O
2017,DATE
;,O
20,NUMBER
(,O
Suppl,O
4,NUMBER
),O
:,O
21650,NUMBER
.,O
CrossRef,O
.,O
Medline,ORGANIZATION
8,NUMBER
.,O
Deeks,PERSON
SG,O
.,O
Overbaugh,PERSON
J,PERSON
.,O
Phillips,PERSON
A,O
.,O
Buchbinder,PERSON
S.,O
HIV,CAUSE_OF_DEATH
infec,O
‐,O
tion,O
.,O
Nat,ORGANIZATION
Global,ORGANIZATION
Health,ORGANIZATION
:,O
Science,O
and,O
Practice,O
2020,DATE
|,O
Volume,O
8,NUMBER
|,O
Number,O
2,NUMBER
